nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Niacin—atherosclerosis	0.149	0.3	CbGbCtD
Hydroxychloroquine—CYP2D6—Simvastatin—atherosclerosis	0.118	0.237	CbGbCtD
Hydroxychloroquine—CYP2D6—Lovastatin—atherosclerosis	0.115	0.232	CbGbCtD
Hydroxychloroquine—CYP2D6—Pravastatin—atherosclerosis	0.115	0.232	CbGbCtD
Hydroxychloroquine—Foetor hepaticus—Ezetimibe—atherosclerosis	0.00529	0.0172	CcSEcCtD
Hydroxychloroquine—Myopathy—Rosuvastatin—atherosclerosis	0.00515	0.0167	CcSEcCtD
Hydroxychloroquine—Foetor hepaticus—Simvastatin—atherosclerosis	0.00504	0.0164	CcSEcCtD
Hydroxychloroquine—Foetor hepaticus—Pravastatin—atherosclerosis	0.00456	0.0148	CcSEcCtD
Hydroxychloroquine—Liver disorder—Ezetimibe—atherosclerosis	0.0044	0.0143	CcSEcCtD
Hydroxychloroquine—Myopathy—Lovastatin—atherosclerosis	0.00436	0.0142	CcSEcCtD
Hydroxychloroquine—Blood disorder—Rosuvastatin—atherosclerosis	0.00432	0.0141	CcSEcCtD
Hydroxychloroquine—Myopathy—Ezetimibe—atherosclerosis	0.00428	0.0139	CcSEcCtD
Hydroxychloroquine—Liver disorder—Simvastatin—atherosclerosis	0.0042	0.0137	CcSEcCtD
Hydroxychloroquine—Myopathy—Simvastatin—atherosclerosis	0.00408	0.0133	CcSEcCtD
Hydroxychloroquine—Hypokinesia—Niacin—atherosclerosis	0.00389	0.0127	CcSEcCtD
Hydroxychloroquine—Liver disorder—Pravastatin—atherosclerosis	0.0038	0.0123	CcSEcCtD
Hydroxychloroquine—Myopathy—Niacin—atherosclerosis	0.00375	0.0122	CcSEcCtD
Hydroxychloroquine—Myopathy—Pravastatin—atherosclerosis	0.00369	0.012	CcSEcCtD
Hydroxychloroquine—Nightmare—Rosuvastatin—atherosclerosis	0.00349	0.0113	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Ezetimibe—atherosclerosis	0.003	0.00976	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Niacin—atherosclerosis	0.00291	0.00946	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Simvastatin—atherosclerosis	0.00286	0.00931	CcSEcCtD
Hydroxychloroquine—Nightmare—Simvastatin—atherosclerosis	0.00276	0.00899	CcSEcCtD
Hydroxychloroquine—Hearing impaired—Pravastatin—atherosclerosis	0.00272	0.00884	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Pravastatin—atherosclerosis	0.00259	0.00841	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00254	0.00826	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Lovastatin—atherosclerosis	0.00253	0.00823	CcSEcCtD
Hydroxychloroquine—Nightmare—Pravastatin—atherosclerosis	0.0025	0.00813	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Ezetimibe—atherosclerosis	0.00248	0.00807	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00238	0.00773	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Simvastatin—atherosclerosis	0.00237	0.00769	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Rosuvastatin—atherosclerosis	0.00231	0.00752	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Niacin—atherosclerosis	0.00218	0.0071	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00215	0.00699	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Pravastatin—atherosclerosis	0.00214	0.00696	CcSEcCtD
Hydroxychloroquine—Deafness—Pravastatin—atherosclerosis	0.0021	0.00683	CcSEcCtD
Hydroxychloroquine—Depression—Rosuvastatin—atherosclerosis	0.00201	0.00655	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00201	0.00654	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.002	0.0065	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Niacin—atherosclerosis	0.002	0.00649	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Ezetimibe—atherosclerosis	0.00192	0.00625	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Lovastatin—atherosclerosis	0.0019	0.00618	CcSEcCtD
Hydroxychloroquine—Chloroquine—TNF—atherosclerosis	0.00188	1	CrCbGaD
Hydroxychloroquine—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00187	0.00608	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Ezetimibe—atherosclerosis	0.00186	0.00606	CcSEcCtD
Hydroxychloroquine—Affect lability—Pravastatin—atherosclerosis	0.00185	0.00601	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Simvastatin—atherosclerosis	0.00183	0.00596	CcSEcCtD
Hydroxychloroquine—Mood swings—Pravastatin—atherosclerosis	0.00178	0.00579	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Simvastatin—atherosclerosis	0.00178	0.00578	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Niacin—atherosclerosis	0.00176	0.00573	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00175	0.0057	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Pravastatin—atherosclerosis	0.00173	0.00564	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00172	0.00559	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.0017	0.00552	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00169	0.0055	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Niacin—atherosclerosis	0.00168	0.00547	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Pravastatin—atherosclerosis	0.00166	0.00539	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00164	0.00533	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Pravastatin—atherosclerosis	0.00161	0.00523	CcSEcCtD
Hydroxychloroquine—Depression—Simvastatin—atherosclerosis	0.0016	0.00519	CcSEcCtD
Hydroxychloroquine—Mental disorder—Rosuvastatin—atherosclerosis	0.00159	0.00517	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00159	0.00516	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00148	0.00482	CcSEcCtD
Hydroxychloroquine—Weight decreased—Pravastatin—atherosclerosis	0.00147	0.00478	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Lovastatin—atherosclerosis	0.00145	0.00472	CcSEcCtD
Hydroxychloroquine—Depression—Pravastatin—atherosclerosis	0.00144	0.00469	CcSEcCtD
Hydroxychloroquine—Angioedema—Rosuvastatin—atherosclerosis	0.00144	0.00469	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00144	0.00467	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Ezetimibe—atherosclerosis	0.00143	0.00463	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Simvastatin—atherosclerosis	0.00136	0.00442	CcSEcCtD
Hydroxychloroquine—Alopecia—Lovastatin—atherosclerosis	0.00136	0.00442	CcSEcCtD
Hydroxychloroquine—Alopecia—Ezetimibe—atherosclerosis	0.00133	0.00433	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Niacin—atherosclerosis	0.00133	0.00431	CcSEcCtD
Hydroxychloroquine—Mental disorder—Ezetimibe—atherosclerosis	0.00132	0.00429	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Niacin—atherosclerosis	0.00132	0.00429	CcSEcCtD
Hydroxychloroquine—Malnutrition—Ezetimibe—atherosclerosis	0.00131	0.00427	CcSEcCtD
Hydroxychloroquine—Visual impairment—Niacin—atherosclerosis	0.00127	0.00414	CcSEcCtD
Hydroxychloroquine—Alopecia—Simvastatin—atherosclerosis	0.00127	0.00413	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00126	0.00411	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00126	0.0041	CcSEcCtD
Hydroxychloroquine—Vision blurred—Lovastatin—atherosclerosis	0.00126	0.0041	CcSEcCtD
Hydroxychloroquine—Mental disorder—Simvastatin—atherosclerosis	0.00126	0.00409	CcSEcCtD
Hydroxychloroquine—Visual impairment—Pravastatin—atherosclerosis	0.00125	0.00407	CcSEcCtD
Hydroxychloroquine—Eye disorder—Niacin—atherosclerosis	0.00123	0.00401	CcSEcCtD
Hydroxychloroquine—Tinnitus—Niacin—atherosclerosis	0.00123	0.004	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Pravastatin—atherosclerosis	0.00123	0.004	CcSEcCtD
Hydroxychloroquine—Angioedema—Lovastatin—atherosclerosis	0.00122	0.00397	CcSEcCtD
Hydroxychloroquine—Anaemia—Ezetimibe—atherosclerosis	0.00121	0.00394	CcSEcCtD
Hydroxychloroquine—Tinnitus—Pravastatin—atherosclerosis	0.00121	0.00394	CcSEcCtD
Hydroxychloroquine—Vertigo—Lovastatin—atherosclerosis	0.0012	0.00391	CcSEcCtD
Hydroxychloroquine—Angioedema—Ezetimibe—atherosclerosis	0.0012	0.0039	CcSEcCtD
Hydroxychloroquine—Leukopenia—Lovastatin—atherosclerosis	0.0012	0.00389	CcSEcCtD
Hydroxychloroquine—Vision blurred—Simvastatin—atherosclerosis	0.00118	0.00383	CcSEcCtD
Hydroxychloroquine—Alopecia—Niacin—atherosclerosis	0.00117	0.00379	CcSEcCtD
Hydroxychloroquine—Anaemia—Simvastatin—atherosclerosis	0.00116	0.00376	CcSEcCtD
Hydroxychloroquine—Malnutrition—Niacin—atherosclerosis	0.00115	0.00374	CcSEcCtD
Hydroxychloroquine—Alopecia—Pravastatin—atherosclerosis	0.00115	0.00373	CcSEcCtD
Hydroxychloroquine—Angioedema—Simvastatin—atherosclerosis	0.00114	0.00372	CcSEcCtD
Hydroxychloroquine—Tension—Niacin—atherosclerosis	0.00113	0.00367	CcSEcCtD
Hydroxychloroquine—Vertigo—Simvastatin—atherosclerosis	0.00112	0.00366	CcSEcCtD
Hydroxychloroquine—Leukopenia—Simvastatin—atherosclerosis	0.00112	0.00364	CcSEcCtD
Hydroxychloroquine—Nervousness—Niacin—atherosclerosis	0.00112	0.00363	CcSEcCtD
Hydroxychloroquine—Tension—Pravastatin—atherosclerosis	0.00111	0.00361	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00111	0.00361	CcSEcCtD
Hydroxychloroquine—Pain—Rosuvastatin—atherosclerosis	0.0011	0.00358	CcSEcCtD
Hydroxychloroquine—Nervousness—Pravastatin—atherosclerosis	0.0011	0.00357	CcSEcCtD
Hydroxychloroquine—Vision blurred—Niacin—atherosclerosis	0.00108	0.00352	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00107	0.00348	CcSEcCtD
Hydroxychloroquine—Vision blurred—Pravastatin—atherosclerosis	0.00107	0.00347	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00105	0.00343	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00105	0.00341	CcSEcCtD
Hydroxychloroquine—Angioedema—Niacin—atherosclerosis	0.00105	0.00341	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00105	0.00341	CcSEcCtD
Hydroxychloroquine—Anaemia—Pravastatin—atherosclerosis	0.00105	0.0034	CcSEcCtD
Hydroxychloroquine—Anorexia—Lovastatin—atherosclerosis	0.00104	0.00338	CcSEcCtD
Hydroxychloroquine—Skin disorder—Ezetimibe—atherosclerosis	0.00104	0.00338	CcSEcCtD
Hydroxychloroquine—Angioedema—Pravastatin—atherosclerosis	0.00103	0.00336	CcSEcCtD
Hydroxychloroquine—Vertigo—Niacin—atherosclerosis	0.00103	0.00336	CcSEcCtD
Hydroxychloroquine—Leukopenia—Niacin—atherosclerosis	0.00103	0.00334	CcSEcCtD
Hydroxychloroquine—Urticaria—Rosuvastatin—atherosclerosis	0.00102	0.00333	CcSEcCtD
Hydroxychloroquine—Oedema—Simvastatin—atherosclerosis	0.00102	0.00332	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00102	0.00331	CcSEcCtD
Hydroxychloroquine—Vertigo—Pravastatin—atherosclerosis	0.00102	0.0033	CcSEcCtD
Hydroxychloroquine—Leukopenia—Pravastatin—atherosclerosis	0.00101	0.00329	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Niacin—atherosclerosis	0.00101	0.00328	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Simvastatin—atherosclerosis	0.001	0.00325	CcSEcCtD
Hydroxychloroquine—Anorexia—Simvastatin—atherosclerosis	0.000973	0.00317	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000971	0.00316	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000949	0.00309	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Lovastatin—atherosclerosis	0.000949	0.00309	CcSEcCtD
Hydroxychloroquine—Fatigue—Lovastatin—atherosclerosis	0.000941	0.00306	CcSEcCtD
Hydroxychloroquine—Oedema—Niacin—atherosclerosis	0.000938	0.00305	CcSEcCtD
Hydroxychloroquine—Pain—Lovastatin—atherosclerosis	0.000934	0.00304	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Ezetimibe—atherosclerosis	0.000931	0.00303	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000924	0.00301	CcSEcCtD
Hydroxychloroquine—Asthenia—Rosuvastatin—atherosclerosis	0.000924	0.00301	CcSEcCtD
Hydroxychloroquine—Oedema—Pravastatin—atherosclerosis	0.000923	0.003	CcSEcCtD
Hydroxychloroquine—Fatigue—Ezetimibe—atherosclerosis	0.000923	0.003	CcSEcCtD
Hydroxychloroquine—Pain—Ezetimibe—atherosclerosis	0.000916	0.00298	CcSEcCtD
Hydroxychloroquine—Pruritus—Rosuvastatin—atherosclerosis	0.000911	0.00296	CcSEcCtD
Hydroxychloroquine—Skin disorder—Niacin—atherosclerosis	0.000911	0.00296	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000904	0.00294	CcSEcCtD
Hydroxychloroquine—Anorexia—Niacin—atherosclerosis	0.000894	0.00291	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000893	0.0029	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Simvastatin—atherosclerosis	0.000888	0.00289	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000882	0.00287	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000881	0.00287	CcSEcCtD
Hydroxychloroquine—Fatigue—Simvastatin—atherosclerosis	0.00088	0.00286	CcSEcCtD
Hydroxychloroquine—Anorexia—Pravastatin—atherosclerosis	0.00088	0.00286	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000876	0.00285	CcSEcCtD
Hydroxychloroquine—Pain—Simvastatin—atherosclerosis	0.000873	0.00284	CcSEcCtD
Hydroxychloroquine—Urticaria—Lovastatin—atherosclerosis	0.000867	0.00282	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Lovastatin—atherosclerosis	0.000863	0.00281	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Lovastatin—atherosclerosis	0.000863	0.00281	CcSEcCtD
Hydroxychloroquine—Dizziness—Rosuvastatin—atherosclerosis	0.000852	0.00277	CcSEcCtD
Hydroxychloroquine—Urticaria—Ezetimibe—atherosclerosis	0.000851	0.00277	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Ezetimibe—atherosclerosis	0.000847	0.00275	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Ezetimibe—atherosclerosis	0.000847	0.00275	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000835	0.00272	CcSEcCtD
Hydroxychloroquine—Somnolence—Niacin—atherosclerosis	0.000834	0.00271	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Niacin—atherosclerosis	0.000815	0.00265	CcSEcCtD
Hydroxychloroquine—Rash—Rosuvastatin—atherosclerosis	0.000812	0.00264	CcSEcCtD
Hydroxychloroquine—Dermatitis—Rosuvastatin—atherosclerosis	0.000812	0.00264	CcSEcCtD
Hydroxychloroquine—Urticaria—Simvastatin—atherosclerosis	0.000811	0.00264	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00081	0.00263	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Simvastatin—atherosclerosis	0.000807	0.00262	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Simvastatin—atherosclerosis	0.000807	0.00262	CcSEcCtD
Hydroxychloroquine—Headache—Rosuvastatin—atherosclerosis	0.000807	0.00262	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Lovastatin—atherosclerosis	0.000804	0.00262	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Pravastatin—atherosclerosis	0.000803	0.00261	CcSEcCtD
Hydroxychloroquine—Pain—Niacin—atherosclerosis	0.000802	0.00261	CcSEcCtD
Hydroxychloroquine—Fatigue—Pravastatin—atherosclerosis	0.000796	0.00259	CcSEcCtD
Hydroxychloroquine—Pain—Pravastatin—atherosclerosis	0.000789	0.00257	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000789	0.00257	CcSEcCtD
Hydroxychloroquine—Asthenia—Lovastatin—atherosclerosis	0.000783	0.00255	CcSEcCtD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—atherosclerosis	0.000781	0.00404	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—atherosclerosis	0.000775	0.004	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Lovastatin—atherosclerosis	0.000772	0.00251	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00077	0.00398	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Ezetimibe—atherosclerosis	0.000768	0.0025	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Niacin—atherosclerosis	0.000767	0.00249	CcSEcCtD
Hydroxychloroquine—Nausea—Rosuvastatin—atherosclerosis	0.000765	0.00249	CcSEcCtD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00076	0.00393	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Ezetimibe—atherosclerosis	0.000758	0.00246	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000755	0.00245	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Simvastatin—atherosclerosis	0.000752	0.00245	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Lovastatin—atherosclerosis	0.000747	0.00243	CcSEcCtD
Hydroxychloroquine—Urticaria—Niacin—atherosclerosis	0.000745	0.00242	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Niacin—atherosclerosis	0.000741	0.00241	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Niacin—atherosclerosis	0.000741	0.00241	CcSEcCtD
Hydroxychloroquine—Urticaria—Pravastatin—atherosclerosis	0.000733	0.00238	CcSEcCtD
Hydroxychloroquine—Asthenia—Simvastatin—atherosclerosis	0.000733	0.00238	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Ezetimibe—atherosclerosis	0.000733	0.00238	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—NFKB1—atherosclerosis	0.000732	0.00378	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Pravastatin—atherosclerosis	0.00073	0.00237	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Pravastatin—atherosclerosis	0.00073	0.00237	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—MAPK3—atherosclerosis	0.000727	0.00376	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—NFKB1—atherosclerosis	0.000723	0.00373	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Simvastatin—atherosclerosis	0.000722	0.00235	CcSEcCtD
Hydroxychloroquine—Dizziness—Lovastatin—atherosclerosis	0.000722	0.00235	CcSEcCtD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK3—atherosclerosis	0.00072	0.00372	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—atherosclerosis	0.00072	0.00372	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—MAPK8—atherosclerosis	0.000719	0.00372	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—NFKB1—atherosclerosis	0.000714	0.00369	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—MAPK8—atherosclerosis	0.00071	0.00367	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Ezetimibe—atherosclerosis	0.000708	0.0023	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—MAPK3—atherosclerosis	0.000707	0.00365	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—MAPK3—atherosclerosis	0.000707	0.00365	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—MAPK8—atherosclerosis	0.000702	0.00363	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—MAPK3—atherosclerosis	0.000701	0.00362	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Simvastatin—atherosclerosis	0.000699	0.00227	CcSEcCtD
Hydroxychloroquine—Vomiting—Lovastatin—atherosclerosis	0.000694	0.00226	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Niacin—atherosclerosis	0.000691	0.00225	CcSEcCtD
Hydroxychloroquine—Rash—Lovastatin—atherosclerosis	0.000688	0.00224	CcSEcCtD
Hydroxychloroquine—Dermatitis—Lovastatin—atherosclerosis	0.000688	0.00224	CcSEcCtD
Hydroxychloroquine—Headache—Lovastatin—atherosclerosis	0.000684	0.00222	CcSEcCtD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—MAPK3—atherosclerosis	0.000682	0.00353	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—MAPK3—atherosclerosis	0.000682	0.00353	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—MAPK3—atherosclerosis	0.000682	0.00353	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Ezetimibe—atherosclerosis	0.000681	0.00221	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Pravastatin—atherosclerosis	0.00068	0.00221	CcSEcCtD
Hydroxychloroquine—Dizziness—Simvastatin—atherosclerosis	0.000675	0.0022	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000675	0.00349	CbGpPWpGaD
Hydroxychloroquine—Rash—Ezetimibe—atherosclerosis	0.000675	0.0022	CcSEcCtD
Hydroxychloroquine—Dermatitis—Ezetimibe—atherosclerosis	0.000675	0.00219	CcSEcCtD
Hydroxychloroquine—Asthenia—Niacin—atherosclerosis	0.000673	0.00219	CcSEcCtD
Hydroxychloroquine—Headache—Ezetimibe—atherosclerosis	0.000671	0.00218	CcSEcCtD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atherosclerosis	0.000666	0.00344	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CCR2—atherosclerosis	0.000664	0.00343	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Niacin—atherosclerosis	0.000663	0.00216	CcSEcCtD
Hydroxychloroquine—Asthenia—Pravastatin—atherosclerosis	0.000662	0.00215	CcSEcCtD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—atherosclerosis	0.000654	0.00338	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Pravastatin—atherosclerosis	0.000653	0.00212	CcSEcCtD
Hydroxychloroquine—Vomiting—Simvastatin—atherosclerosis	0.000649	0.00211	CcSEcCtD
Hydroxychloroquine—Nausea—Lovastatin—atherosclerosis	0.000648	0.00211	CcSEcCtD
Hydroxychloroquine—Rash—Simvastatin—atherosclerosis	0.000644	0.00209	CcSEcCtD
Hydroxychloroquine—Dermatitis—Simvastatin—atherosclerosis	0.000643	0.00209	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Niacin—atherosclerosis	0.000642	0.00209	CcSEcCtD
Hydroxychloroquine—Headache—Simvastatin—atherosclerosis	0.00064	0.00208	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—atherosclerosis	0.000638	0.0033	CbGpPWpGaD
Hydroxychloroquine—Nausea—Ezetimibe—atherosclerosis	0.000636	0.00207	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Pravastatin—atherosclerosis	0.000632	0.00205	CcSEcCtD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—atherosclerosis	0.000631	0.00326	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—MAPK3—atherosclerosis	0.000628	0.00325	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000624	0.00323	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—EDN1—atherosclerosis	0.000622	0.00322	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—MAPK3—atherosclerosis	0.00062	0.00321	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Niacin—atherosclerosis	0.00062	0.00202	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TLR2—atherosclerosis	0.000617	0.00319	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—MAPK3—atherosclerosis	0.000613	0.00317	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—atherosclerosis	0.000612	0.00316	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Pravastatin—atherosclerosis	0.000611	0.00199	CcSEcCtD
Hydroxychloroquine—Nausea—Simvastatin—atherosclerosis	0.000607	0.00197	CcSEcCtD
Hydroxychloroquine—Vomiting—Niacin—atherosclerosis	0.000596	0.00194	CcSEcCtD
Hydroxychloroquine—Rash—Niacin—atherosclerosis	0.000591	0.00192	CcSEcCtD
Hydroxychloroquine—Dermatitis—Niacin—atherosclerosis	0.000591	0.00192	CcSEcCtD
Hydroxychloroquine—Headache—Niacin—atherosclerosis	0.000587	0.00191	CcSEcCtD
Hydroxychloroquine—Vomiting—Pravastatin—atherosclerosis	0.000587	0.00191	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—FCGR3A—atherosclerosis	0.000585	0.00302	CbGpPWpGaD
Hydroxychloroquine—Rash—Pravastatin—atherosclerosis	0.000582	0.00189	CcSEcCtD
Hydroxychloroquine—Dermatitis—Pravastatin—atherosclerosis	0.000582	0.00189	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—atherosclerosis	0.000581	0.003	CbGpPWpGaD
Hydroxychloroquine—Headache—Pravastatin—atherosclerosis	0.000578	0.00188	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—NFKB1—atherosclerosis	0.000571	0.00295	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—atherosclerosis	0.000569	0.00294	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—MAPK3—atherosclerosis	0.000567	0.00293	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—NFKB1—atherosclerosis	0.000565	0.00292	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—atherosclerosis	0.000562	0.0029	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK8—atherosclerosis	0.000561	0.0029	CbGpPWpGaD
Hydroxychloroquine—Nausea—Niacin—atherosclerosis	0.000557	0.00181	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CD14—atherosclerosis	0.000556	0.00287	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—MAPK8—atherosclerosis	0.000555	0.00287	CbGpPWpGaD
Hydroxychloroquine—Nausea—Pravastatin—atherosclerosis	0.000548	0.00178	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT1—atherosclerosis	0.000536	0.00277	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—atherosclerosis	0.000531	0.00275	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atherosclerosis	0.000526	0.00272	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CCR2—atherosclerosis	0.000525	0.00271	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—atherosclerosis	0.000517	0.00267	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—atherosclerosis	0.000517	0.00267	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—atherosclerosis	0.000512	0.00265	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—APOE—atherosclerosis	0.000506	0.00262	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—atherosclerosis	0.000499	0.00258	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—atherosclerosis	0.000499	0.00258	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—atherosclerosis	0.000499	0.00258	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—MAPK3—atherosclerosis	0.00049	0.00253	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TLR2—atherosclerosis	0.000488	0.00252	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—MAPK3—atherosclerosis	0.000485	0.00251	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FCGR3A—atherosclerosis	0.000462	0.00239	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—atherosclerosis	0.000459	0.00237	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AGER—atherosclerosis	0.000456	0.00236	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—atherosclerosis	0.000454	0.00234	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PRKCG—atherosclerosis	0.000451	0.00233	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—atherosclerosis	0.000448	0.00232	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—atherosclerosis	0.000444	0.0023	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRH1—atherosclerosis	0.000442	0.00229	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CD36—atherosclerosis	0.000441	0.00228	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD14—atherosclerosis	0.00044	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT1—atherosclerosis	0.000424	0.00219	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—atherosclerosis	0.000418	0.00216	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—atherosclerosis	0.000414	0.00214	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NCF1—atherosclerosis	0.000409	0.00212	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PDGFB—atherosclerosis	0.000407	0.0021	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CRP—atherosclerosis	0.000398	0.00205	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CCR2—atherosclerosis	0.000387	0.002	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CYBA—atherosclerosis	0.000385	0.00199	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TLR4—atherosclerosis	0.000381	0.00197	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AGER—atherosclerosis	0.00036	0.00186	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD40—atherosclerosis	0.000359	0.00186	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TLR2—atherosclerosis	0.000359	0.00186	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP7A1—atherosclerosis	0.000359	0.00185	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—atherosclerosis	0.000359	0.00185	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PRKCG—atherosclerosis	0.000357	0.00184	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—atherosclerosis	0.000354	0.00183	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000354	0.00183	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CD36—atherosclerosis	0.000349	0.0018	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APOA4—atherosclerosis	0.000347	0.00179	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP27A1—atherosclerosis	0.000332	0.00171	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT1—atherosclerosis	0.000331	0.00171	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000327	0.00169	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD14—atherosclerosis	0.000324	0.00167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NCF1—atherosclerosis	0.000324	0.00167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PDGFB—atherosclerosis	0.000322	0.00166	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL4—atherosclerosis	0.00032	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CRP—atherosclerosis	0.000314	0.00162	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—VCAM1—atherosclerosis	0.000313	0.00162	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CCR2—atherosclerosis	0.000306	0.00158	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CYBA—atherosclerosis	0.000304	0.00157	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—SOCS3—atherosclerosis	0.000303	0.00157	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TLR4—atherosclerosis	0.000301	0.00156	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000301	0.00156	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APOA2—atherosclerosis	0.000299	0.00154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—UTS2—atherosclerosis	0.000285	0.00147	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TLR2—atherosclerosis	0.000284	0.00147	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD40—atherosclerosis	0.000284	0.00147	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL18—atherosclerosis	0.000276	0.00143	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD40LG—atherosclerosis	0.000275	0.00142	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CX3CR1—atherosclerosis	0.000273	0.00141	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASR—atherosclerosis	0.000273	0.00141	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CX3CL1—atherosclerosis	0.000268	0.00138	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AGER—atherosclerosis	0.000266	0.00137	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PRKCG—atherosclerosis	0.000263	0.00136	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD36—atherosclerosis	0.000257	0.00133	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD14—atherosclerosis	0.000256	0.00132	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CNR2—atherosclerosis	0.000254	0.00131	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—VCAM1—atherosclerosis	0.000247	0.00128	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SOCS3—atherosclerosis	0.00024	0.00124	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PDGFB—atherosclerosis	0.000237	0.00122	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CRP—atherosclerosis	0.000232	0.0012	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NFKB1—atherosclerosis	0.000231	0.0012	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK8—atherosclerosis	0.000227	0.00118	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VWF—atherosclerosis	0.000226	0.00117	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APOC3—atherosclerosis	0.000225	0.00116	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LDLR—atherosclerosis	0.000224	0.00116	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TLR4—atherosclerosis	0.000222	0.00115	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL18—atherosclerosis	0.000219	0.00113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL3—atherosclerosis	0.000218	0.00113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD40LG—atherosclerosis	0.000218	0.00113	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ICAM1—atherosclerosis	0.000213	0.0011	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AGER—atherosclerosis	0.00021	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NCF1—atherosclerosis	0.000209	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PRKCG—atherosclerosis	0.000208	0.00107	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CD36—atherosclerosis	0.000203	0.00105	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—MAPK3—atherosclerosis	0.000199	0.00103	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCR2—atherosclerosis	0.000198	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EDNRA—atherosclerosis	0.000198	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CYBA—atherosclerosis	0.000197	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PLAT—atherosclerosis	0.000193	0.000995	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GHRL—atherosclerosis	0.000193	0.000995	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PARP1—atherosclerosis	0.000193	0.000995	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PDGFB—atherosclerosis	0.000187	0.000968	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CRP—atherosclerosis	0.000183	0.000946	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NFKB1—atherosclerosis	0.000183	0.000945	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK8—atherosclerosis	0.00018	0.000929	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TLR4—atherosclerosis	0.000175	0.000907	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KNG1—atherosclerosis	0.000169	0.000873	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ICAM1—atherosclerosis	0.000168	0.000869	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AGTR1—atherosclerosis	0.000168	0.000868	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PLG—atherosclerosis	0.000164	0.000846	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNG—atherosclerosis	0.000162	0.000837	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MAPK3—atherosclerosis	0.000157	0.000811	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SOCS3—atherosclerosis	0.000155	0.000801	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP3—atherosclerosis	0.00015	0.000774	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF2—atherosclerosis	0.000149	0.00077	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	0.000148	0.000765	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	0.000146	0.000755	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—atherosclerosis	0.000145	0.000751	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APOB—atherosclerosis	0.000145	0.000748	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—atherosclerosis	0.000144	0.000747	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EDN1—atherosclerosis	0.000142	0.000736	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL5—atherosclerosis	0.000141	0.00073	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LPL—atherosclerosis	0.000138	0.000714	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NFKB1—atherosclerosis	0.000135	0.000696	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PRKCG—atherosclerosis	0.000134	0.000694	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—atherosclerosis	0.000134	0.000692	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK8—atherosclerosis	0.000132	0.000685	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SPP1—atherosclerosis	0.000131	0.000676	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNG—atherosclerosis	0.000128	0.000662	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—STAT3—atherosclerosis	0.000121	0.000626	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFB—atherosclerosis	0.000121	0.000626	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AGT—atherosclerosis	0.000118	0.000611	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APOE—atherosclerosis	0.000116	0.000598	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LEP—atherosclerosis	0.000116	0.000598	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAPK3—atherosclerosis	0.000116	0.000598	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—atherosclerosis	0.000115	0.000593	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CAV1—atherosclerosis	0.000115	0.000593	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APOA1—atherosclerosis	0.000114	0.000592	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—atherosclerosis	0.000114	0.00059	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ESR1—atherosclerosis	0.000111	0.000571	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—F2—atherosclerosis	0.000109	0.000564	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NFKB1—atherosclerosis	0.000107	0.00055	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—atherosclerosis	0.000106	0.000547	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	0.000105	0.000543	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK8—atherosclerosis	0.000105	0.000541	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CG—atherosclerosis	0.000105	0.00054	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—INS—atherosclerosis	9.89e-05	0.000511	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PLTP—atherosclerosis	9.87e-05	0.00051	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCL2—atherosclerosis	9.73e-05	0.000503	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—atherosclerosis	9.57e-05	0.000495	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1—atherosclerosis	9.57e-05	0.000495	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAPK3—atherosclerosis	9.15e-05	0.000473	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SERPINE1—atherosclerosis	9.09e-05	0.00047	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOS3—atherosclerosis	8.68e-05	0.000448	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LTA4H—atherosclerosis	8.56e-05	0.000442	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCG8—atherosclerosis	8.56e-05	0.000442	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—atherosclerosis	8.46e-05	0.000437	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—atherosclerosis	7.8e-05	0.000403	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—atherosclerosis	7.7e-05	0.000398	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—atherosclerosis	6.96e-05	0.00036	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NFKB1—atherosclerosis	6.89e-05	0.000356	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK8—atherosclerosis	6.77e-05	0.00035	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCG1—atherosclerosis	6.77e-05	0.00035	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—atherosclerosis	6.69e-05	0.000346	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FABP4—atherosclerosis	6.36e-05	0.000329	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LCAT—atherosclerosis	6.36e-05	0.000329	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—atherosclerosis	6.25e-05	0.000323	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOA4—atherosclerosis	6.24e-05	0.000323	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—atherosclerosis	6.19e-05	0.00032	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—atherosclerosis	6.17e-05	0.000319	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	6.13e-05	0.000317	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAPK3—atherosclerosis	5.91e-05	0.000306	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—atherosclerosis	5.74e-05	0.000296	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	5.67e-05	0.000293	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	5.37e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOA2—atherosclerosis	5.37e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	5.37e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALOX15—atherosclerosis	5.37e-05	0.000278	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCG5—atherosclerosis	5.31e-05	0.000274	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LPA—atherosclerosis	5.13e-05	0.000265	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BGN—atherosclerosis	4.97e-05	0.000257	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOA5—atherosclerosis	4.92e-05	0.000254	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	4.73e-05	0.000245	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALOX5—atherosclerosis	4.57e-05	0.000236	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—atherosclerosis	4.32e-05	0.000223	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NAMPT—atherosclerosis	4.1e-05	0.000212	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LIPC—atherosclerosis	4.07e-05	0.00021	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOC3—atherosclerosis	4.05e-05	0.000209	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LDLR—atherosclerosis	4.02e-05	0.000208	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—atherosclerosis	3.99e-05	0.000206	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CETP—atherosclerosis	3.93e-05	0.000203	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SCARB1—atherosclerosis	3.76e-05	0.000194	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMGCR—atherosclerosis	3.55e-05	0.000184	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCA1—atherosclerosis	3.17e-05	0.000164	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMOX1—atherosclerosis	2.72e-05	0.00014	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOB—atherosclerosis	2.6e-05	0.000135	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTM1—atherosclerosis	2.53e-05	0.000131	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LPL—atherosclerosis	2.49e-05	0.000128	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPX1—atherosclerosis	2.43e-05	0.000125	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CD36—atherosclerosis	2.36e-05	0.000122	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.24e-05	0.000116	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARA—atherosclerosis	2.2e-05	0.000113	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AGT—atherosclerosis	2.13e-05	0.00011	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOE—atherosclerosis	2.08e-05	0.000108	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CAV1—atherosclerosis	2.06e-05	0.000107	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOA1—atherosclerosis	2.06e-05	0.000106	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.88e-05	9.72e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARG—atherosclerosis	1.81e-05	9.38e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—INS—atherosclerosis	1.78e-05	9.2e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALB—atherosclerosis	1.63e-05	8.43e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NOS3—atherosclerosis	1.56e-05	8.07e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.43e-05	7.38e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—atherosclerosis	7.18e-06	3.71e-05	CbGpPWpGaD
